Preparation and Antitumor Activity of a Tamibarotene-Furoxan Derivative |
Wang, Xue-Jian
(School of Pharmacy and Biology Science, Weifang Medical University)
Duan, Yu (School of Pharmacy and Biology Science, Weifang Medical University) Li, Zong-Tao (Research and Development Department, Shandong Qidu Pharmaceutical Co. Ltd.) Feng, Jin-Hong (Shandong Analysis and Test Center, Shandong Academy of Sciences) Pan, Xiang-Po (Clinical Laboratory, Weifang People's Hospital) Zhang, Xiu-Rong (School of Pharmacy and Biology Science, Weifang Medical University) Shi, Li-Hong (School of Pharmacy and Biology Science, Weifang Medical University) Zhang, Tao (Research and Development Department, Shandong Qidu Pharmaceutical Co. Ltd.) |
1 | Bellos F, Mahlknecht U (2008). Valproic acid and all-trans retinoic acid: meta-analysis of a palliative treatment regimen in AML and MDS patients. Onkologie, 31, 629-33 |
2 | Bian HY, Feng JH, Li MY, et al (2011). Novel antileukemic agents derived from tamibarotene and nitric oxide donors. Bioorg Med Chem Lett, 21, 7025-9 DOI |
3 | Boiani M, Cerecetto H, Gonzalez M, et al (2001). 1, 2, 5-Oxadiazole N-oxide derivatives as potential anti-cancer agents: synthesis and biological evaluation. Part IV. Eur J Med Chem, 36, 771-82 DOI |
4 | Cerecetto H, Porcal W (2005). Pharmacological properties of furoxans and benzofuroxans: recent developments. Mini Rev Med Chem, 5, 57-71 DOI |
5 | Endo Y, Iijima T, Yaguchi K et al (2001). Structure-Activity study of retinoid agonists bearing substituted dicarba-closododecaborane. Relation between retinoidal activity and conformation of two aromatic nuclei. Bioorg Med Chem Lett, 11, 1307-11 DOI |
6 | Hirst DG, Robson T (2010). Nitrosative stress as a mediator of apoptosis: implications for cancer therapy. Curr Pharm Des, 16, 45-55 DOI ScienceOn |
7 | Huang ME, Ye YC, Chen SR, et al (1988). Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72, 567-72 |
8 | Huerta S, Chilka S, Bonavida B (2008). Nitric oxide donors: novel cancer therapeutics (review). Int J Oncol, 33, 909-27 |
9 | Konstantin C, Chiara R, Loretta L, et al (2011). Nitric oxide donor doxorubicins accumulate into doxorubicin-resistant human colon cancer cells inducing cytotoxicity. ACS Med Chem Lett, 2, 494-7 DOI |
10 | Kitamura K, Hoshi S, Koike M, et al (2000). Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t (11;17) in combination with all-trans retinoic acid. Br J Haematol, 108, 696-702 DOI ScienceOn |
11 | Li XH, Huang ML, Wang SM, et al (2013). Selective inhibition of bicyclic tetrapeptide histone deacetylase inhibitor on HDAC4 and K562 leukemia cell. Asian Pac J Cancer Prev, 14, 7095-100 과학기술학회마을 DOI ScienceOn |
12 | Lippman SM, Kavanagh JJ, Paredes-Espinoza M, et al (1992). 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst, 84, 241-5 DOI |
13 | Miwako I, Kagechika H (2007). Tamibarotene. Drugs Today, 43, 563-8 DOI |
14 | Savickiene J, Treigyte G, Borutinskaite V, et al (2006). The histone deacetylase inhibitor FK228 distinctly sensitizes the human leukemia cells to retinoic acid-induced differentiation. Ann N Y Acad Sci, 1091, 368-84 DOI ScienceOn |
15 | Wang H, Gui SY, Chen FH, et al (2013). New insights into 4-amino-2-tri-fluoromethyl-phenyl ester inhibition of cell growth and migration in the A549 lung adenocarcinoma cell line. Asian Pac J Cancer Prev, 14, 7265-70 과학기술학회마을 DOI ScienceOn |
16 | Zou ZH, Lan XB, Qian H, et al (2011). Synthesis and evaluation of furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline as anticancer and multidrug resistance reversal agents. Bioorg Med Chem Lett, 21, 5934-8 DOI |
17 | Wang PG, Xian M, Tang X, et al (2002). Nitric oxide donors: chemical activities and biological applications. Chem Rev, 102, 1091-134 DOI ScienceOn |
18 | Warrell RP, Jr, He LZ, et al (1998). Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J Natl Cancer Inst, 90, 1621-5 DOI |
19 | Wu Q, Dawson MI, Zheng Y, et al (1997). Inhibition of transretinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids. Mol Cell Biol, 17, 6598-608 |